Compounds > tifluadom
Page last updated: 2024-09-03

tifluadom and buprenorphine

tifluadom has been researched along with buprenorphine in 4 studies

Compound Research Comparison

Studies
(tifluadom)		Trials
(tifluadom)		Recent Studies (post-2010)
(tifluadom)		Studies
(buprenorphine)		Trials
(buprenorphine)		Recent Studies (post-2010) (buprenorphine)
78007,2731,2233,826

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19902 (50.00)18.7374
1990's2 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, C; Li, JG; Liu-Chen, LY; Luo, LY; Zhu, J1
Dykstra, LA; Negus, SS; Picker, MJ1
Cowan, A; Murray, C1
Hayes, AG; Skingle, M; Tyers, MB1

Other Studies

4 other study(ies) available for tifluadom and buprenorphine

ArticleYear
Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands.
    The Journal of pharmacology and experimental therapeutics, 1997, Volume: 282, Issue:2

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adenylate Cyclase Toxin; Animals; Binding Sites; Cell Membrane; CHO Cells; Cholera Toxin; Cloning, Molecular; Cricetinae; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Guanosine 5'-O-(3-Thiotriphosphate); Guanosine Diphosphate; Humans; Kinetics; Magnesium; Pertussis Toxin; Pyrrolidines; Receptors, Opioid, kappa; Recombinant Proteins; Sodium; Sulfur Radioisotopes; Virulence Factors, Bordetella

1997
Interactions between mu and kappa opioid agonists in the rat drug discrimination procedure.
    Psychopharmacology, 1990, Volume: 102, Issue:4

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Benzodiazepines; Benzomorphans; Buprenorphine; Discrimination, Psychological; Dose-Response Relationship, Drug; Drug Interactions; Fentanyl; Male; Morphine; Pentobarbital; Pyrrolidines; Rats; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Opioid, mu

1990
Neuroadaptation of rats to kappa agonists U-50,488 and tifluadom.
    NIDA research monograph, 1988, Volume: 81

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adaptation, Physiological; Animals; Behavior, Animal; Benzodiazepines; Buprenorphine; Male; Naloxone; Pyrrolidines; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, kappa; Stereotyped Behavior

1988
Reversal by beta-funaltrexamine of the antinociceptive effect of opioid agonists in the rat.
    British journal of pharmacology, 1986, Volume: 88, Issue:4

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Benzodiazepines; Buprenorphine; Cyclazocine; Ethylketocyclazocine; Fentanyl; Male; Naltrexone; Pain; Pyrrolidines; Rats; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Opioid, mu

1986